Licensed telehealth providers. Mounjaro, Zepbound, and compounded tirzepatide with free online doctor consultation. Delivered to your door nationwide.
Take a quick online assessment and get matched with a licensed physician. Medication delivered to your door in 2-3 days.
Start My Assessment — Free VisitThree simple steps to get tirzepatide delivered to your door
Answer a few quick questions about your health and weight loss goals. Takes less than 5 minutes.
A licensed physician reviews your case and prescribes the right tirzepatide protocol within 24 hours.
Your tirzepatide arrives at your door within 2-3 business days with free discreet shipping.
Choose the tirzepatide option that fits your goals and budget
Personalized compounded tirzepatide prepared by trusted U.S. licensed compounding pharmacies. Same active ingredient as Mounjaro and Zepbound. All-inclusive plan with medication, doctor care and ongoing support.
FDA-approved tirzepatide by Eli Lilly for type 2 diabetes. Often used off-label for weight loss with insurance coverage.
FDA-approved tirzepatide specifically for chronic weight management. Same molecule as Mounjaro, different indication.
Alternative GLP-1 option if tirzepatide isn't right for you. Same active ingredient as Ozempic and Wegovy. All-inclusive plan with weekly injection, doctor care and support.
Clinical outcomes from SURMOUNT-1 trial at 72 weeks
Multiple payment and savings options available
Many commercial plans cover GLP-1 therapy for eligible patients. Your provider can submit prior authorization for Mounjaro or Zepbound.
Tirzepatide prescribed by a licensed provider is an eligible expense for Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA).
Medicare Part D may cover Mounjaro for eligible beneficiaries with qualifying type 2 diabetes. Zepbound is generally not yet covered for weight loss.
Most telehealth providers offer flexible monthly payment plans with no interest. Start tirzepatide treatment today and spread the cost over time.
Eli Lilly offers savings card programs for Mounjaro and Zepbound to commercially insured patients who meet eligibility requirements.
Select your state to find licensed providers near you
Tirzepatide is the first FDA-approved dual GLP-1/GIP receptor agonist for weight management. Unlike single-agonist medications such as semaglutide (Ozempic, Wegovy), tirzepatide activates two gut hormone receptors, producing greater weight loss and improved metabolic outcomes. It works by slowing gastric emptying, reducing appetite, signaling fullness to the brain, and improving insulin sensitivity. In the SURMOUNT-1 trial, patients lost an average of 22.5% of body weight over 72 weeks on the highest dose.
Mounjaro (FDA-approved 2022) is indicated for type 2 diabetes, while Zepbound (FDA-approved 2023) is specifically approved for chronic weight management. Both contain the same active ingredient — tirzepatide — at identical doses. Compounded tirzepatide, prepared by licensed 503A/503B compounding pharmacies, offers an affordable alternative with free online doctor consultation compared to $1,000+ for brand-name products.
Many commercial insurance plans cover Mounjaro and Zepbound with prior authorization. HSA and FSA accounts can also be used to pay with pre-tax dollars. For those without coverage, compounded tirzepatide makes treatment accessible at a fraction of the brand-name cost. Our licensed telehealth physicians serve patients in all 50 states.
Join 50,000+ patients who chose telehealth tirzepatide. Your licensed physician is ready to review your assessment within 24 hours.
Start My Assessment — Free Visit